These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 18199910)

  • 1. Assessment of organ-specific neutron equivalent doses in proton therapy using computational whole-body age-dependent voxel phantoms.
    Zacharatou Jarlskog C; Lee C; Bolch WE; Xu XG; Paganetti H
    Phys Med Biol; 2008 Feb; 53(3):693-717. PubMed ID: 18199910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of whole-body phantom designs to estimate organ equivalent neutron doses for secondary cancer risk assessment in proton therapy.
    Moteabbed M; Geyer A; Drenkhahn R; Bolch WE; Paganetti H
    Phys Med Biol; 2012 Jan; 57(2):499-515. PubMed ID: 22217682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary neutron doses received by paediatric patients during intracranial proton therapy treatments.
    Sayah R; Farah J; Donadille L; Hérault J; Delacroix S; De Marzi L; De Oliveira A; Vabre I; Stichelbaut F; Lee C; Bolch WE; Clairand I
    J Radiol Prot; 2014 Jun; 34(2):279-96. PubMed ID: 24704989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutron equivalent doses and associated lifetime cancer incidence risks for head & neck and spinal proton therapy.
    Athar BS; Paganetti H
    Phys Med Biol; 2009 Aug; 54(16):4907-26. PubMed ID: 19641238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of out-of-field photon doses in 6 MV IMRT and neutron doses in proton therapy for adult and pediatric patients.
    Athar BS; Bednarz B; Seco J; Hancox C; Paganetti H
    Phys Med Biol; 2010 May; 55(10):2879-91. PubMed ID: 20427856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the secondary neutral radiation in proton therapy: toward an indirect in vivo dosimetry.
    Carnicer A; Letellier V; Rucka G; Angellier G; Sauerwein W; Herault J
    Med Phys; 2012 Dec; 39(12):7303-16. PubMed ID: 23231280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body dose equivalent including neutrons is similar for 6 MV and 15 MV IMRT, VMAT, and 3D conformal radiotherapy.
    Hauri P; Schneider U
    J Appl Clin Med Phys; 2019 Mar; 20(3):56-70. PubMed ID: 30791198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method.
    Titt U; Zheng Y; Vassiliev ON; Newhauser WD
    Phys Med Biol; 2008 Jan; 53(2):487-504. PubMed ID: 18185001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutron dosimetry in organs of an adult human phantom using linacs with multileaf collimator in radiotherapy treatments.
    Martinez-Ovalle SA; Barquero R; Gomez-Ros JM; Lallena AM
    Med Phys; 2012 May; 39(5):2854-66. PubMed ID: 22559658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age.
    Zacharatou Jarlskog C; Paganetti H
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):228-35. PubMed ID: 18571337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo study of neutron dose equivalent during passive scattering proton therapy.
    Zheng Y; Newhauser W; Fontenot J; Taddei P; Mohan R
    Phys Med Biol; 2007 Aug; 52(15):4481-96. PubMed ID: 17634645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurements of the neutron dose equivalent for various radiation qualities, treatment machines and delivery techniques in radiation therapy.
    Hälg RA; Besserer J; Boschung M; Mayer S; Lomax AJ; Schneider U
    Phys Med Biol; 2014 May; 59(10):2457-68. PubMed ID: 24778349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of beam incidence and irradiation parameters on stray neutron doses to healthy organs of pediatric patients treated for an intracranial tumor with passive scattering proton therapy.
    Bonfrate A; Farah J; De Marzi L; Delacroix S; Hérault J; Sayah R; Lee C; Bolch WE; Clairand I
    Phys Med; 2016 Apr; 32(4):590-9. PubMed ID: 27050170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of different dose scoring methods on organ-specific neutron dose calculations in proton therapy.
    Jarlskog CZ; Paganetti H
    Phys Med Biol; 2008 Sep; 53(17):4523-32. PubMed ID: 18677040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulation of organ-specific patient effective dose due to secondary neutrons in proton radiation treatment.
    Jiang H; Wang B; Xu XG; Suit HD; Paganetti H
    Phys Med Biol; 2005 Sep; 50(18):4337-53. PubMed ID: 16148397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monte Carlo simulations of neutron spectral fluence, radiation weighting factor and ambient dose equivalent for a passively scattered proton therapy unit.
    Zheng Y; Fontenot J; Taddei P; Mirkovic D; Newhauser W
    Phys Med Biol; 2008 Jan; 53(1):187-201. PubMed ID: 18182696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Out-of-field contributions for IMRT and volumetric modulated arc therapy measured using gafchromic films and compared to calculations using a superposition/convolution based treatment planning system.
    Van den Heuvel F; Defraene G; Crijns W; Bogaerts R
    Radiother Oncol; 2012 Oct; 105(1):127-32. PubMed ID: 22300610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a Monte Carlo Framework for Out-of-Field Dose Calculations in Proton Therapy.
    De Saint-Hubert M; Verbeek N; Bäumer C; Esser J; Wulff J; Nabha R; Van Hoey O; Dabin J; Stuckmann F; Vasi F; Radonic S; Boissonnat G; Schneider U; Rodriguez M; Timmermann B; Thierry-Chef I; Brualla L
    Front Oncol; 2022; 12():882489. PubMed ID: 35756661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT.
    Alem-Bezoubiri A; Suleiman SA; Behidj I; Mazrou H; Chami AC
    Appl Radiat Isot; 2022 Feb; 180():110065. PubMed ID: 34933226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT.
    Reft CS; Runkel-Muller R; Myrianthopoulos L
    Med Phys; 2006 Oct; 33(10):3734-42. PubMed ID: 17089839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.